BRIEF-Sangamo Therapeutics updates on SB-525 investigational hemophilia A gene therapy – Reuters
Thorold News |
BRIEF-Sangamo Therapeutics updates on SB-525 investigational hemophilia A gene therapy
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA |
